142 related articles for article (PubMed ID: 33758991)
1. Impact of population-based or targeted BMD interventions on fracture incidence.
Harvey NC; Kanis JA; Liu E; Vandenput L; Lorentzon M; Cooper C; McCloskey E; Johansson H
Osteoporos Int; 2021 Oct; 32(10):1973-1979. PubMed ID: 33758991
[TBL] [Abstract][Full Text] [Related]
2. Fracture Risk Indices From DXA-Based Finite Element Analysis Predict Incident Fractures Independently From FRAX: The Manitoba BMD Registry.
Leslie WD; Luo Y; Yang S; Goertzen AL; Ahmed S; Delubac I; Lix LM
J Clin Densitom; 2019; 22(3):338-345. PubMed ID: 30852033
[TBL] [Abstract][Full Text] [Related]
3. Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.
Ettinger B; Ensrud KE; Blackwell T; Curtis JR; Lapidus JA; Orwoll ES;
Osteoporos Int; 2013 Apr; 24(4):1185-93. PubMed ID: 23179575
[TBL] [Abstract][Full Text] [Related]
4. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
5. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
Leslie WD; Lix LM; Binkley N
Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
[TBL] [Abstract][Full Text] [Related]
7. Impact of spine-hip discordance on fracture risk assessment and treatment qualification in Canada: the Manitoba BMD registry.
Leslie WD; Morin SN; Lix LM; Binkley N
Arch Osteoporos; 2020 Jun; 15(1):85. PubMed ID: 32514615
[TBL] [Abstract][Full Text] [Related]
8. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
[TBL] [Abstract][Full Text] [Related]
9. How well do the FRAX (Australia) and Garvan calculators predict incident fractures? Data from the Geelong Osteoporosis Study.
Holloway-Kew KL; Zhang Y; Betson AG; Anderson KB; Hans D; Hyde NK; Nicholson GC; Pocock NA; Kotowicz MA; Pasco JA
Osteoporos Int; 2019 Oct; 30(10):2129-2139. PubMed ID: 31317250
[TBL] [Abstract][Full Text] [Related]
10. Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?
Leslie WD; Morin SN; Lix LM; Majumdar SR
Osteoporos Int; 2014 Dec; 25(12):2817-24. PubMed ID: 25092059
[TBL] [Abstract][Full Text] [Related]
11. Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program.
Leslie WD; Aubry-Rozier B; Lix LM; Morin SN; Majumdar SR; Hans D
Bone; 2014 Oct; 67():10-4. PubMed ID: 24998455
[TBL] [Abstract][Full Text] [Related]
12. Administrative healthcare data applied to fracture risk assessment.
Yang S; Leslie WD; Morin SN; Lix LM
Osteoporos Int; 2019 Mar; 30(3):565-571. PubMed ID: 30554259
[TBL] [Abstract][Full Text] [Related]
13. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
[TBL] [Abstract][Full Text] [Related]
14. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.
Lalmohamed A; Welsing PM; Lems WF; Jacobs JW; Kanis JA; Johansson H; De Boer A; De Vries F
Osteoporos Int; 2012 Mar; 23(3):861-9. PubMed ID: 22120910
[TBL] [Abstract][Full Text] [Related]
15. Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry.
Leslie WD; Shevroja E; Johansson H; McCloskey EV; Harvey NC; Kanis JA; Hans D
Osteoporos Int; 2018 Mar; 29(3):751-758. PubMed ID: 29392355
[TBL] [Abstract][Full Text] [Related]
16. Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.
Tamaki J; Iki M; Kadowaki E; Sato Y; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
Osteoporos Int; 2011 Dec; 22(12):3037-45. PubMed ID: 21279504
[TBL] [Abstract][Full Text] [Related]
17. High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.
Leslie WD; Majumdar SR; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
Osteoporos Int; 2012 Jan; 23(1):391-7. PubMed ID: 21365460
[TBL] [Abstract][Full Text] [Related]
18. A comparison of case-finding strategies in the UK for the management of hip fractures.
Johansson H; Kanis JA; Oden A; Compston J; McCloskey E
Osteoporos Int; 2012 Mar; 23(3):907-15. PubMed ID: 22234810
[TBL] [Abstract][Full Text] [Related]
19. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.
Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD;
Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508
[TBL] [Abstract][Full Text] [Related]
20. FREM predicts 10-year incident fracture risk independent of FRAX® probability: a registry-based cohort study.
Leslie WD; Möller S; Skjødt MK; Yan L; Abrahamsen B; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA; Rubin KH
Osteoporos Int; 2022 Jul; 33(7):1457-1463. PubMed ID: 35175395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
